Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society
2018/05/30 by Andrew M. D. Wolf, Andrew M.D. Wolf, Elizabeth T. H. Fontham +19 · 41 citations
Medicine · #Colorectal Cancer Screening and Detection #Genetic factors in colorectal cancer #Gastric Cancer Management and Outcomes
paper · pdf · doi:10.3322/caac.21457
Abstract
In the United States, colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults and the second leading cause of death from cancer. For this guideline update, the American Cancer Society (ACS) used an existing systematic evidence review of the CRC screening literature and microsimulation modeling analyses, including a new evaluation of the age to begin screening by race and sex and additional modeling that incorporates changes in US CRC incidence. Screening with any one of multiple options is associated with a significant reduction in CRC incidence through the detection and removal of adenomatous polyps and other precancerous lesions and with a reduction in mortality through incidence reduction and early detection of CRC. Results from modeling analyses identified efficient and model-recommendable strategies that started screening at age 45 years. The ACS Guideline Development Group applied the Grades of Recommendations, Assessment, Development, and Evaluation (GRADE) criteria in developing and rating the recommendations. The ACS recommends that adults aged 45 years and older with an average risk of CRC undergo regular screening with either a high-sensitivity stool-based test or a structural (visual) examination, depending on patient preference and test availability. As a part of the screening process, all positive results on noncolonoscopy screening tests should be followed up with timely colonoscopy. The recommendation to begin screening at age 45 years is a qualified recommendation. The recommendation for regular screening in adults aged 50 years and older is a strong recommendation. The ACS recommends (qualified recommendations) that: 1) average-risk adults in good health with a life expectancy of more than 10 years continue CRC screening through the age of 75 years; 2) clinicians individualize CRC screening decisions for individuals aged 76 through 85 years based on patient preferences, life expectancy, health status, and prior screening history; and 3) clinicians discourage individuals older than 85 years from continuing CRC screening. The options for CRC screening are: fecal immunochemical test annually; high-sensitivity, guaiac-based fecal occult blood test annually; multitarget stool DNA test every 3 years; colonoscopy every 10 years; computed tomography colonography every 5 years; and flexible sigmoidoscopy every 5 years. CA Cancer J Clin 2018;68:250-281. © 2018 American Cancer Society.
Citations
Cited by
- Colorectal cancer statistics, 2020
- A blueprint for cancer screening and early detection: Advancing screening’s contribution to cancer control
- British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines
- Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer
- Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults
- Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
- Multi-Cancer Early Detection: The New Frontier in Cancer Early Detection
- Colorectal cancer statistics, 2026
- Burn the Fat: Colon Cancer Tumors Are Skilled at Lipid Storage During Obesity
- Colon, colorectal, and all cancer incidence increase in the young due to appendix reclassification
- Colorectal cancer molecular profiling: Opportunities for early detection
- Regional patterns of early-onset colorectal cancer from the GEOCODE (Global Early-Onset COlorectal Cancer DatabasE)-European consortium: retrospective cohort study
- Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
- The case for early identification and intervention of chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- Characterization of Korean Colorectal Cancer Reveals Novel Driver Gene and Clinically Relevant Mutations
- Epigenetic age and accelerated aging phenotypes: a tumor biomarker for predicting colorectal cancer
- Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention. [europepmc]
- The colorectal cancer epidemic: challenges and opportunities for primary, secondary and tertiary prevention. [europepmc]
- Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women. [europepmc]
- Colorectal Cancer and Nutrition. [europepmc]
- Clinical and molecular characterization of early-onset colorectal cancer. [europepmc]
- Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. [europepmc]
- Changes in colorectal cancer incidence in seven high-income countries: a population-based study. [europepmc]
- Annual Report to the Nation on the Status of Cancer, Featuring Cancer in Men and Women Age 20-49 Years. [europepmc]
- Cancer statistics for adults aged 85 years and older, 2019. [europepmc]
- Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. [europepmc]
- Risk Factors Associated With Early-Onset Colorectal Cancer. [europepmc]
- Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies. [europepmc]
- British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England post-polypectomy and post-colorectal cancer resection surveillance guidelines. [europepmc]
- Annual report to the nation on the status of cancer, part I: National cancer statistics. [europepmc]
- Comprehensive review of targeted therapy for colorectal cancer. [europepmc]
- Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer. [europepmc]
- Rising incidence of early-onset colorectal cancer - a call to action. [europepmc]
- An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer. [europepmc]
- Genetic and biological hallmarks of colorectal cancer. [europepmc]
- Global colorectal cancer burden in 2020 and projections to 2040. [europepmc]
- Dysbiosis of human gut microbiome in young-onset colorectal cancer. [europepmc]
- Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. [europepmc]
- Current and future colorectal cancer screening strategies. [europepmc]
- Young-onset colorectal cancer. [europepmc]
- Cancer statistics, 2025. [europepmc]
Related